APA (7th ed.) Citation

SM, F., MA, F., D, S., Y, W., TM, G., M, L., . . . AA, J. (2022). CRISPR-mediated TGFBR2 knockout renders human ovarian cancer tumor-infiltrating lymphocytes resistant to TGF-β signaling. Journal for immunotherapy of cancer, 10(7), . https://doi.org/10.1136/jitc-2021-003750

Chicago Style (17th ed.) Citation

SM, Fix, et al. "CRISPR-mediated TGFBR2 Knockout Renders Human Ovarian Cancer Tumor-infiltrating Lymphocytes Resistant to TGF-β Signaling." Journal for Immunotherapy of Cancer 10, no. 7 (2022). https://doi.org/10.1136/jitc-2021-003750.

MLA (9th ed.) Citation

SM, Fix, et al. "CRISPR-mediated TGFBR2 Knockout Renders Human Ovarian Cancer Tumor-infiltrating Lymphocytes Resistant to TGF-β Signaling." Journal for Immunotherapy of Cancer, vol. 10, no. 7, 2022, https://doi.org/10.1136/jitc-2021-003750.